COMMUNIQUÉS West-GlobeNewswire

Vaxil: Management and Operational Update

03/04/2025 - 22:05

Not for distribution by US newswire or in United States NESS-ZIONA, Israel, April 03, 2025 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“ Vaxil ” or the “ Company ”) (TSX VENTURE: VXL), is pleased to make the following updates [...]

Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress

03/04/2025 - 22:05

Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor (“EGFRi”) to bring in $10 million upfront payment and expand dataset to combination therapy New interim data [...]

AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity

03/04/2025 - 22:03

VALENCIA, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the U.S. commercial [...]

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03/04/2025 - 22:01

CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today [...]

I-Mab Reports Full Year 2024 Financial Results and Provides Business Update

03/04/2025 - 22:01

Continued positive momentum in givastomig Phase 1b combination trial in first-line gastric cancer, with topline dose escalation data (n=17) expected in 2H 2025 Enrollment completed ahead of schedule in the first [...]

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03/04/2025 - 22:00

BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]

Sanofi: Information concerning the total number of voting rights and shares - February 2025

03/04/2025 - 20:08

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]

Sanofi: Informations relatives au nombre de droits de vote et d'actions - FEVRIER 2025

03/04/2025 - 20:08

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]

Best SARMs For Cutting, Bulking & Muscle Growth 2025: Top Fat Loss Sarms Stack For Sale On The Market - CrazyBulk

03/04/2025 - 19:05

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Welcome to the world of SARMs, the selective androgen receptor modulators that have gained popularity in the fitness and bodybuilding community. SARMs offer a unique approach [...]

HealthRecon Connect Achieves ISO 22301:2019 Certification for Business Continuity Management

03/04/2025 - 18:22

DALLAS, April 03, 2025 (GLOBE NEWSWIRE) -- HealthRecon Connect is proud to announce that it has been awarded the ISO 22301:2019 certification, an internationally recognized standard for Business Continuity Management [...]

OSE Immunotherapeutics Presents Preclinical Updates in Immuno-Oncology at AACR Annual Meeting 2025

03/04/2025 - 18:00

OSE Immunotherapeutics Presents Preclinical Updates in Immuno-Oncology at AACR Annual Meeting 2025 OSE-CYTOMASK®, a new CIS-Demasking 1 cytokine bispecific technology. CLEC-1, a novel immune checkpoint target. NANTES, [...]

OSE Immunotherapeutics présente ses dernières avancées précliniques en Immuno-Oncologie - Au congrès annuel 2025 de l’AACR

03/04/2025 - 18:00

OSE Immunotherapeutics présente ses dernières avancées précliniques en Immuno-Oncologie Au congrès annuel 2025 de l’AACR OSE-CYTOMASK®, une nouvelle technologie bispécifique de CIS-Démasquage 1 des cytokines. CLEC-1, [...]

SAFE - REPORT DE LA PUBLICATION DES RESULTATS ANNUELS ET DU RAPPORT FINANCIER ANNUEL 2024

03/04/2025 - 18:00

REPORT DE LA PUBLICATION DES RESULTATS ANNUELS ET DU RAPPORT FINANCIER ANNUEL 2024 Fleurieux-sur-l’Arbresle - France - le 3 avril 2025 à 18h . Safe Group annonce le report de la publication des résultats 2024 et du [...]

EssilorLuxottica and Roger Federer Extend Exclusive Global Eyewear Collaboration Between the RF Brand and Oliver Peoples

03/04/2025 - 18:00

EssilorLuxottica and Roger Federer Extend Exclusive Global Eyewear Collaboration Between the RF Brand and Oliver Peoples Paris, France (3 April 2025) – EssilorLuxottica and Roger Federer announce today the renewal of [...]

EssilorLuxottica et Roger Federer étendent la collaboration mondiale exclusive entre la marque RF et Oliver Peoples pour des collections de lunettes

03/04/2025 - 18:00

EssilorLuxottica et Roger Federer étendent la collaboration mondiale exclusive entre la marque RF et Oliver Peoples pour des collections de lunettes Paris, France (3 avril 2025) – EssilorLuxottica et Roger Federer [...]

Valneva SE Shareholding Declaration - March 2025

03/04/2025 - 17:45

VALNEVA Declaration of shares and voting rights March 31, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, [...]

Déclaration d'actions et de droits de vote de la société Valneva SE - Mars 2025

03/04/2025 - 17:45

VALNEVA Déclaration d’actions et de droits de vote 31 mars 2025 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : 6 rue [...]

Resolutions from the Annual General Meeting 2025

03/04/2025 - 17:43

Today, the Annual General Meeting of Novonesis (Novozymes A/S) was conducted. The following resolutions were made: Approval of the audited Annual Report for 2024 Approval of distribution of profit with payment of an [...]

Arialief Vitamins Reviews & Complaints (EXPOSED 2025) Arialief For Neuropathy and Nerve Health

03/04/2025 - 17:20

Why is Arialief more advantageous in today's era? FINDLAY, Ohio, April 03, 2025 (GLOBE NEWSWIRE) -- Arialief Vitamins is a pure product mainly designed to aid sciatic nerve health. The supplement is prepared with [...]